Scrip
AstraZeneca CEO admits struggle in FDA funding campaign
29 January 2010
Christopher Spillane
David Brennan has admitted that his lobbying for more funding for the
US FDA is yet to bear much fruit. Speaking exclusively with
Scrip at
AstraZeneca's financial results in London, the CEO was frank in his assessment that progress has been slow but he remains confident that he will eventually...
Please Login to read the full article.
29 January 2010
Christopher Spillane
Please Login to read the full article.
RELATED CONTENT
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
